ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Targeting OPA1-Mediated Mitochondrial Fusion Contributed to Celastrol's Anti-Tumor Angiogenesis Effect

Li, Gaofu; Zhou, Lei; Deng, Huifang; Huang, Congshu; Wang, Ningning; Yue, Lanxin; Zhang, Pengfei; Zhou, Yongqiang; Zhou, Wei*; Gao, Yue*广东药学院; y
Pharmaceutics2023-1DOI: 10.3390/pharmaceutics15010048
2被引11阅读
引用收藏
分享

摘要

Celastrol, an active triterpenoid extracted from one of the most famous traditional Chinese medicines (TCMs), Tripterygium wilfordii Hook.f., is a novel anti-cancer drug with significant anti-angiogenesis activity. However, the exact molecular mechanisms underlying its anti-tumor angiogenesis effect remain unclear. The process of angiogenesis needs lots of energy supply, which mostly derives from mitochondria, the "energy factory" in our body. This study shows that celastrol exerts visible suppression on tumor growth and angiogenesis in a cell-derived xenograft (CDX). Likewise, it reduced the tube formation and migration of human umbilical vein endothelial cells (HUVECs), suppressed the energy metabolism of mitochondria in the Seahorse XF Mito Stress Test, and triggered mitochondrial fragmentation and NF-kappa B activation. Mechanically, celastrol downregulated the expression of mitochondrial-sharping protein optic atrophy protein 1 (OPA1), which was further estimated by the OPA1 knockdown model of HUVECs. Specifically, celastrol directly suppressed OPA1 at the mRNA level by inhibiting the phosphorylation of STAT3, and stattic (STAT3 inhibitor) showed the same effects on OPA1 suppression and anti-angiogenesis activity. Overall, this study indicates that celastrol inhibits tumor angiogenesis by suppressing mitochondrial function and morphology via the STAT3/OPA1/P65 pathway and provides new insight for mitochondrion-targeted cancer therapy.

学科与关键词

关键词
celastroltumor angiogenesismitochondrion-targeted medicineOPA1
相关
加载中…
  • Celastrol Inhibits the Proliferation and Induces Apoptosis of Colorectal Cancer Cells via Downregulating NF-κB/COX-2 Signaling Pathways
    Zhang, Hua; Zhao, Xiaojin; Shang, Fajun; Sun, Huan; Zheng, Xu; Zhu, Jiabin*Anti-Cancer Agents in Medicinal Chemistry, 2022, 22(10): 1921-1932.被引 4
  • Identifying the Effect of Celastrol Against Ovarian Cancer With Network Pharmacology and In Vitro Experiments
    Wang, Xuan; Liu, Qiong; Wu, Sisi; Xu, Nana; Li, Hua*; Feng, Aihua*Frontiers in Pharmacology, 2022, 13: 739478.被引 5
  • Quantitative chemical proteomics reveals anti-cancer targets of Celastrol in HCT116 human colon cancer cells
    Zhang, Xing; Zhou, Jing; Zhu, Yongping; Wong, Yin Kwan; Liu, Dandan; Gao, Peng; Lin, Qingsong; Zhang, Jianbin*; Chen, Xiao*; Wang, Jigang*PHYTOMEDICINE, 2022, 101: 154096.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Pharmaceutics
发表日期
2023-01
卷期
第 15 卷, 第 1 期
页码
48
DOI
10.3390/pharmaceutics15010048
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82274198]

作者

  • L

    Li, Gaofu (第一作者)

    beijing inst radiat med

  • Z

    Zhou, Lei

    guangdong pharmaceut univ

查看全部 10 位作者收起作者
  • D

    Deng, Huifang

    beijing inst radiat med

  • H

    Huang, Congshu

    tianjin univ tradit chinese med

  • W

    Wang, Ningning

    beijing inst radiat med

  • Y

    Yue, Lanxin

    beijing inst radiat med

  • Z

    Zhang, Pengfei

    beijing inst radiat med

  • Z

    Zhou, Yongqiang

    beijing inst radiat med

  • Z

    Zhou, Wei (通讯)

    beijing inst radiat med

  • G

    Gao, Yue (通讯)

    beijing inst radiat med · guangdong pharmaceut univ · tianjin univ tradit chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417